SUMMARY
  • EU (EFSA) maximum permitted levels for aflatoxin in non-dairy complete feed is 20 µg/kg, below this level aflatoxin presence may still negatively impact health and reduce animal performance.
  • Anpario’s Anpro range significantly reduces aflatoxin and secondary metabolite (AfM1) concentration in the blood and liver tissue of swine.
  • Anpro is an effective toxin binder against high levels of aflatoxin in feed.
BACKGROUND
  • Mycotoxins are produced by moulds and may still be present in processed feed and bedding.
  • Mycotoxins are stable compounds which are resistant to heat and chemical treatments.
  • Mycotoxicosis can cause reduced feed intake, impaired growth, as well as infertility in swine with retarded puberty in gilts and in severe cases can lead to prolapse of the uterus and death.
TRIAL DESIGN

An independent in vivo trial was conducted by Alimetrics (Finland) to demonstrate the efficacy of Anpro to bind aflatoxin (AfB1 and AfM1) in swine feed. A total of 32 healthy Duroc cross commercial boars were randomly allocated to 16 pens, 2 pigs per pen for a duration of 29 days. A commercial basal diet was fed for 7 days followed by treatment diets for 21 days. Aflatoxin was added at a dose of 20 µg/kg to T1 (basal diet) and T2 (basal + 5 kg/t Anpro) and fed ad libitum. Blood samples were taken from day 7 to 29 with 8 replicate pens per treatment and liver samples were collected at the end of the trial (day 29).

RESULTS
  • Aflatoxin (AfB1) and its main metabolite (AfM1) were significantly reduced in the blood and liver of animals receiving Anpro.
  • Anpro gave numerical benefits in growth performance (not shown) for weight gain and feed efficiency.
  • Anpro significantly reduced AfB1 transfer from feed, therefore reducing the aflatoxin risk to swine.